Molecular basis of ameloblastoma pathogenesis: a review
DOI:
https://doi.org/10.21142/10.21142/2523-2754-1203-2024-212Keywords:
ameloblastoma, bone resorption, SHH protein human, MAP kinase signaling system, molecular biologyAbstract
Ameloblastoma is the most common and highly invasive benign odontogenic tumor. Its pathogenesis is not yet fully understood. Objective: To describe the most important molecular findings that promote the proliferative activity of ameloblastoma and the factors involved that encourage invasion into surrounding bone tissues. Methodology: A search for scientific evidence was conducted through the following databases: Science Direct, Medline, Wiley, Web of Science, and Google Scholar. A total of 32 articles were reviewed, with inclusion criteria being articles published in English and Spanish; descriptive and analytical studies, narrative and systematic reviews published from January 2015 to June 2021. Letters to the editor were excluded. Results: The biological molecular findings that allow ameloblastoma to invade surrounding tissues involve alterations in the RANK/RANKL/OPG pathways, transforming growth factor beta (TGF-β), Wnt/β-catenin pathway, and matrix metalloproteinases, as well as alterations in MAPK and SHH pathways that facilitate the proliferation and tumor development of ameloblastoma. Conclusions: These findings are fundamental for a better understanding of the pathways involved in the pathogenesis of ameloblastoma.
Downloads
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.